The Impact and Reliability of Tissue Segmentation on In Vivo Magnetic Resonance Spectroscopy Metabolite Quantification
PURPOSE: Quantification of metabolite concentrations using MRS requires tissue-dependent signal corrections. Accurate estimation of voxel tissue composition is therefore essential. Commonly used brain tissue segmentation tools differ in their algorithms and implementation, potentially introducing variability in MRS-derived concentration estimates. This study investigates the impact and reliability of tissue segmentation on metabolite quantification. METHODS: Three segmentation tools (ANTs, FSL, SPM) were evaluated using an in vivo test-retest MRI/MRS dataset. Voxelwise GM/WM/CSF fractions were applied to compute tissue-corrected total creatine (tCr) concentrations. Linear mixed-effects modeling, variance-component partitioning, and intraclass correlation coefficients (ICCs) quantified tool-, session-, and participant-related variance under permutation scenarios that isolated segmentation- and MRS-related effects. As a benchmark for segmentation performance, comparisons with manually segmented data were conducted across three brain regions. RESULTS: Segmentation tools produced systematically different tissue fractions that propagated into differences in tCr concentration estimates. Variance partitioning attributed 56.8%, 50.0%, and 51.3% of total tCr concentration variability to segmentation tool across the three permutations, with participant-specific factors accounting for 34.7%, 36.2%, and 28.5%, respectively. When segmentation variability was held constant, test-retest reliability was high (ICC > 0.8) but dropped to ∼0.5 when both segmentation and MRS variability varied. Agreement with manual segmentation was region- and tool-dependent, with the lowest agreement in the thalamus. CONCLUSION: Tissue segmentation contributes substantially to the variability in MRS-derived metabolite concentration estimates. These results underscore the need for transparent segmentation reporting and data sharing to ensure reproducibility and cross-study comparability in MRS research.
Authors
- Helge J. Zöllner (ORCID: https://orcid.org/0000-0002-7148-292X)
- Aaron T. Gudmundson (ORCID: https://orcid.org/0000-0001-5104-0959)
- Georg Oeltzschner (ORCID: https://orcid.org/0000-0003-3083-9811)
- Karl Landheer (ORCID: https://orcid.org/0000-0001-5012-3007)
- Candace C. Fleischer (ORCID: https://orcid.org/0000-0003-3265-2276)
- Kay C. Igwe (ORCID: https://orcid.org/0000-0002-9909-9930)
- Mark E. Mikkelsen
- Jaimie J. Lee (ORCID: https://orcid.org/0009-0009-6246-2773)
- J. K. G. Kramer
- Niklaus Zölch
- Jessica Archibald
- Jamie Near
- Antonia Kaiser
Institutions
- Georgia Institute of Technology (US)
- Sunnybrook Health Science Centre (CA)
- University of British Columbia (CA)
- Johns Hopkins University (US)
- Emory University (US)
- Regeneron (United States) (US)
- University of Zurich (CH)
- Cornell University (US)
- Centre d'Imagerie BioMedicale (CH)
- Sunnybrook Hospital (CA)
- Weill Cornell Medicine (US)
- École Polytechnique Fédérale de Lausanne (CH)
- University of Baltimore (US)
- Columbia University (US)
Publication Details
- Journal
- Magnetic Resonance in Medicine
- Published
- 2026-04-10
- DOI
- https://doi.org/10.1002/mrm.70380
- Primary Topic
- Advanced MRI Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health